Drug and Therapeutics Bulletin 2003;41:1-4; doi:10.1136/dtb.2003.4111
Copyright © 2003 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Drugs for disruptive features in dementia

It is estimated that around 750,000 people in the UK have dementia and, of these, 60% will have behavioural changes or psychological symptoms.^1–3 These features tend to occur in clusters, of which the five most readily recognised are characterised by aggression, apathy, depression, psychomotor agitation or psychosis.⁴ Here, we review the place of drug therapy in the management of patients in whom these features are disruptive.

This article has been cited by other articles:

				How safe are antipsychotics in dementia? DTB, November 1, 2007; 45(11): 81 - 85. [Abstract] [Full Text] [PDF]

				D. P. Alldred, D. R. Petty, P. Bowie, A. G. Zermansky, and D. K. Raynor Antipsychotic prescribing patterns in care homes and relationship with dementia Psychiatr. Bull., September 1, 2007; 31(9): 329 - 332. [Abstract] [Full Text] [PDF]

				C. Flohr and H. C Williams Evidence based management of atopic eczema Arch. Dis. Child. Ed. Pract., October 1, 2004; 89(2): ep35 - ep39. [Full Text] [PDF]